[go: up one dir, main page]

PE20091726A1 - Propagacion de ortomixoviridae - Google Patents

Propagacion de ortomixoviridae

Info

Publication number
PE20091726A1
PE20091726A1 PE2008001863A PE2008001863A PE20091726A1 PE 20091726 A1 PE20091726 A1 PE 20091726A1 PE 2008001863 A PE2008001863 A PE 2008001863A PE 2008001863 A PE2008001863 A PE 2008001863A PE 20091726 A1 PE20091726 A1 PE 20091726A1
Authority
PE
Peru
Prior art keywords
virus
orthomixoviridae
tipo
family
influentza
Prior art date
Application number
PE2008001863A
Other languages
English (en)
Inventor
Carla Christina Schrier
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of PE20091726A1 publication Critical patent/PE20091726A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16161—Methods of inactivation or attenuation
    • C12N2710/16164—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material
    • C12N2760/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C12N2760/16152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

REFERIDA A UN METODO PARA PROPAGAR EL VIRUS DE LA FAMILIA ORTOMIXOVIRIDAE MEDIANTE UNA LINEA CELULAR Mpf DE HURON QUE TIENE UN NUMERO CROMOSOMICO DE 2N=38, DONDE DICHO VIRUS DE LA FAMILIA ORTOMIXOVIRIDAE ES UN VIRUS INFLUENZA TIPO A, B O C, PREFERENTEMENTE, TIPO A O B Y DONDE DICHO METODO CONSITE EN LA INFECCION DE UNA LINEA CELULAR DE HURON CON EL VIRUS DE LA FAMILIA ORTOMIXOVIRIDAE Y LA POSTERIOR COSECHA DE LA PROGENIE VIRAL
PE2008001863A 2007-11-02 2008-10-30 Propagacion de ortomixoviridae PE20091726A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98478407P 2007-11-02 2007-11-02
EP07119867 2007-11-02

Publications (1)

Publication Number Publication Date
PE20091726A1 true PE20091726A1 (es) 2009-11-13

Family

ID=39722699

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001863A PE20091726A1 (es) 2007-11-02 2008-10-30 Propagacion de ortomixoviridae

Country Status (5)

Country Link
AR (1) AR069142A1 (es)
PE (1) PE20091726A1 (es)
TW (1) TW200936758A (es)
UY (1) UY31449A1 (es)
WO (1) WO2009056628A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011006880A1 (en) * 2009-07-14 2011-01-20 Intervet International B.V. Lawsonia intracellularis propagation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
US6743631B1 (en) * 1998-03-17 2004-06-01 North Shore University Hospital Research Corporation Use of human serum resistant vector particles and cell lines for human gene therapy

Also Published As

Publication number Publication date
AR069142A1 (es) 2009-12-30
TW200936758A (en) 2009-09-01
WO2009056628A1 (en) 2009-05-07
UY31449A1 (es) 2009-05-29

Similar Documents

Publication Publication Date Title
CL2020000685A1 (es) Nucleósidos sustituidos, nucleótidos y análogos de estos.
CL2008003794A1 (es) Virus de la estomatitis vesicular geneticamente modificado (vsv) que comprende por lo menos una mutacion de aminoacido en una region de alguna de las proteinas m, g y l del virus; metodo para producirlo; composicion inmunogenica que lo comprende; metodo para adaptar un virus en un cultivo celular.
CR9076A (es) Metodo y materiales para conferir resistencia a las pestes y patogenos de plantas
CO6410304A2 (es) Combinación de un inhibidor de nucleósido polimerasa con un inhibidor de proteasa macrocíclica y su uso en el tratamiento de hepatitis c, fibrosis hepática y función hepática alterada
EA200970996A1 (ru) Стволовые клеточные линии, полученные из эмбрионов утки, для производства вирусных вакцин
MX2012002365A (es) Generación de lineas de linfocitos t citotóxicos con especificidad contra antígenos tumorales multiples o virus múltiples.
PE20120571A1 (es) Produccion de titulos elevados de polivirus para la produccion de vacunas
AR079504A1 (es) Uso combinado de vip 3ab y cry1fa para el manejo de insectos resistentes
UY33667A (es) Compuestos antivirales
CL2009002207A1 (es) Compuestos derivados de 3-hidroxi-5-(9h-purin-9-il)tetrahidrofuran-2-il, inhibidor de la replicacion de arn viral dependiente de arn; composicion farmaceutica; uso para el tratamiento de hepatitis c.
CO6270240A2 (es) Arn bicatenario con lipido modificado que tiene un potente efecto de interferencia del arn
AR079505A1 (es) Uso de cry1da en combinacion con cry1ca para el manejo de insectos resistentes
UY32699A (es) Compuestos antivirales eficaces para inhibir la replicación del virus de la hepatitis c ("hcv"), procesos, composiciones, y métodos relacionados
CL2008003020A1 (es) Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado, que comprende generar celulas que expresan la proteina g de la vsv a partir de un gen vsv optimizado, infectar dichas celulas con el vsv atenuado, y recuperar los virus dle cultivo; composicion que comprende al virus atenuado y kit para producir el virus.
EA200870304A1 (ru) Псевдоинфекционный флавивирус и его применение
GT200900097A (es) Inhibidores de la proteasa ns3 del hcv.
BR112017007431A2 (pt) compósitos termoplásticos de fibra longa híbridos
CL2008003821A1 (es) Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado
ECSP20084442A (es) Tiofenocarboxamidas sustituidas y análogos de las mismas
CL2015003388A1 (es) Sistema constructivo de arquitectura modular con piezas universales e intercambiables entre si.
MX387420B (es) Producción de virus en cultivos celulares.
CR20160178A (es) Derivados de desoxinojirimicina y sus métodos de uso
CO2021013970A2 (es) Células t específicas del antígeno del virus multi-respiratorio y métodos para fabricar y usar el mismo terapéuticamente
AR117877A1 (es) Rhabdovirus recombinante que codifica ccl21
MX2020004063A (es) Sistemas y metodos para producir celulas b modificadas geneticamente para expresar anticuerpos seleccionados.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal